Molecular Detection of Prostate Cancer with PROGENSA(R) PCA3 (ITV Story)

Prostate cancer (PCa) is the second most commonly diagnosed malignancy and a leading cause of cancer death in men across the globe. Current practices for detecting PCa utilize serum PSA and DRE as indications for biopsy and identify approximately 25% of patients with PCa. Unfortunately this means that 75% of biopsies are unnecessary, creating a considerable burden in terms of cost and patient discomfort. PCA3 is a prostate-specific gene that is highly overexpressed in prostate tumors ...

» View the original video «

YouTube | February 11, 2009

Tags:. .overexpressed. .pca. .biopsies. .biopsy. .molecular